In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0272781 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Najat Bouchmaa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Technology, Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immuno-Pharmacology, Sultan Moulay Sl…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lalla Salma Foundation.
Abstract (Originalsprache)
Women’s breast cancer is one of the most significant healthcare issues for the human race that demands a proactive strategy for a cure. In this study, the cytotoxic activity (MTT assay) of two natural steroidal compounds, protodioscin and dioscin, against two major subtypes of human breast cancer estrogen receptor-positive (ER-positive)/MCF-7 and triple-negative breast cancer (TNBC)/MDA-MB-468), was assessed. The clonogenic capacity was evaluated using the clonogenic assay. Oxidative stress was determined by measuring the formation of malondialdehyde and H 2 O 2 and the assessment of total antioxidant enzyme activities (SOD, GPx, GR, and TrxR). Protodioscin and dioscin were highly cytotoxic against the tested cell lines (1.53 μM
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Science and Technology, Team of Experimental Oncology and Natural Substances, Cellular and Molecular Immuno-Pharmacology, Sultan Moulay Slimane University, Beni-Mellal, Morocco.
- Institute of Medical and Biological Sciences, Mohammed VI Polytechnic University (UM6P), Ben-Guerir, Morocco.
- Faculty of Science and Technology, Laboratory of Biochemistry and Molecular Genetics, Abdelmalek Essaadi University, Tangier, Morocco.
- Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, Messina, Italy.
ORCID-Profile: Najat Bouchmaa, Francesco Cacciola
Förderung
- Lalla Salma Foundation
Zitieren
APA
Bouchmaa, N., Ben Mrid, R., Bouargalne, Y., Ajouaoi, S., Cacciola, F., El Fatimy, R., Nhiri, M., & Zyad, A. (2023). In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer. PLOS ONE. https://doi.org/10.1371/journal.pone.0272781
Vancouver
Bouchmaa N, Ben Mrid R, Bouargalne Y, Ajouaoi S, Cacciola F, El Fatimy R, et al. In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer. PLOS ONE. 2023. doi:10.1371/journal.pone.0272781
BibTeX
@article{Bouchmaa2023,
author = {Bouchmaa, Najat and Ben Mrid, Reda and Bouargalne, Youssef and Ajouaoi, Sana and Cacciola, Francesco and El Fatimy, Rachid and Nhiri, Mohamed and Zyad, Abdelmajid},
title = {In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0272781}
}
EUVIMED